Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Visit http://indiaer.blogspot.com/ for complete details �� ��
Cipla Ltd
|
Disappointment continues; Maintain Reduce
|
REDUCE
CMP: Rs303 Target Price: Rs283
n Cipla’s Q1FY12 results were below expectation with a) Revenues up 9% to Rs15.5bn b) EBITDA up 2% to Rs3.6bn and c) APAT down 11% to Rs2.4bn
n Subdued growth in revenues was mainly due to 8% growth in Exports which was led by 22% growth in API sales. Domestic business grew below industry rate at 10%
n Acute segment witnessed intense competition from industry peers during the quarter. Respiratory segment continues to do well for the company
n With increasing competition in domestic market, slow ramp-up in exports & higher overheads at Indore SEZ plant – we re-iterate reduce on the stock with a target price of Rs283 (16xFY13 EPS of Rs17.7)
No comments:
Post a Comment